METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1FOXM1D potentiates PKM2‐mediated tumor glycolysis and angiogenesis2020 · 77 citations
2. 2Colorectal cancer statistics, 20202020 · 5,130 citations
3. 3Tumor glycolysis as a target for cancer therapy: progress and prospects2013 · 1,472 citations
4. 4Understanding the Intersections between Metabolism and Cancer Biology2017 · 2,402 citations
5. 5Targeting cancer metabolism in the era of precision oncology2021 · 1,203 citations